ArticlePharmaceuticals (Basel, Switzerland)2021

Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin.

Joaquim Bosch-Barrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.